Skip to Main Content
Directory of Faculty Research Interests
YSM Home

INFORMATION FOR

DownloadHi-Res Photo

Lynn D. Wilson

MD, MPH, FASTRO
Professor of Therapeutic Radiology and of Dermatology; Executive Vice Chairman, Therapeutic Radiology; Deputy Chief Medical Officer for Radiation Oncology Services, Yale Cancer Center, Smilow Cancer Hospital ; Director of Clinical Affairs, Clinical Program Leader, Therapeutic Radiology, Yale Cancer Center; Associate Director of the Residency Training Program, Therapeutic Radiology

Contact Information

Lynn D. Wilson, MD, MPH, FASTRO

Office Location

Mailing Address

  • Therapeutic Radiology

    P. O. Box 208040

    New Haven, CT 06520-8040

    United States

Related Links

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile

Research Summary

The T-cell receptor is encoded by a gamma-delta and an alpha-beta gene complex. As the T-cell matures, the first rearrangement occurs in the gamma-delta gene complex. If this initial rearrangement is successful in producing a non-host reactive protein, such cells develop into mature CD3+, gamma-delta+, CD4-, CD8-, lymphocytes. Some of these cells migrate to the skin and others circulate within the peripheral blood. When this primary rearrangement is unproductive, the alpha-beta T-cell receptor gene complexes then undergo rearrangement, to produce CD3+, alpha-beta+, CD4+, CD8+ cells. Such cells circulate in the blood in a ratio of approximately 2-3:1, and constitute approximately 70% of all lymphocytes. After exit from the thymus to the circulation, T-cells undergo further maturation; skin is one site where maturation occurs in the presence of a variety of cytokines and skin-specific cell adhesion molecules. Not all T-cells migrate to and differentiate in the skin, as only those with homing receptors for cutaneous vascular adressins will do so.

Several theories have been proposed to explain the pathogenesis of the disorder known as cutaneous T-cell lymphoma (CTCL), or mycosis fungoides (MF). The first of two leading hypothesis proposes that MF is a disorder of malignant helper CD4+ T-cells, with a single neoplastic clone present at the very start of the disease process. The second hypothesis postulates a two stage process: a phase of chronic antigenic stimulation which results in a benign polyclonal proliferation of T lymphocytes, in which one clone is mutated (by polymerase errors, exposure to endogenous oxygenating agents, or an exogenous mutagen) and dominates the T-cell infiltrate. Cells are stimulated to develop "malignant potential," and to proliferate freely in the skin subsequently producing lesions clinically consistent with CTCL.

Weiss et. al. clearly demonstrated that cutaneous T-cell lymphoma (Mycosis Fungoides) is a disorder resulting from an expansion of a neoplastic clone of T-cells with characteristic rearrangements in T-cell receptor genes. Therefore, it should be possible to determine whether a "clinical recurrence" derives from the original neoplastic clone or represents a different neoplastic clonal T-cell expansion (which would reveal a second primary) by comparing the T-cell receptors (and/or the genes which have been rearranged to produce the receptor) in the primary lesion and the recurrence. This is an example of one area of research which our group has pursued.

Girardi M, Heald P.W., Wilson L.D.: The Pathogenesis of Mycosis Fungoides. New England Journal of Medicine 350:1978, 2004)

Specialized Terms: Cutaneous Lymphoma; Lung Cancer; Total Skin Electron Beam Therapy

Coauthors

Research Interests

Dermatology; Lung Neoplasms; Mycosis Fungoides; Lymphoma, T-Cell, Cutaneous; Radiation Oncology

Selected Publications

  • 245 Factors associated with in-hospital mortality in mycosis fungoides patientsKing A, Lee V, Mirza F, Jairam V, Yu J, Park H, Girardi M, Wilson L, An Y. 245 Factors associated with in-hospital mortality in mycosis fungoides patients Journal Of Investigative Dermatology 2021, 141: s44. DOI: 10.1016/j.jid.2021.02.267.
  • CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are IrradiatedPeters G, Gao S, Knowlton C, Zhang A, Evans S, Higgins S, Wilson L, Saltmarsh N, Picone M, Moran M. CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are Irradiated Journal Of The National Comprehensive Cancer Network 2021, 19: clo21-025. DOI: 10.6004/jnccn.2020.7707.
  • Predictive Value of PET-CT in Patients with T-Cell Lymphoma Undergoing Autologous and Allogeneic Stem Cell TransplantIsufi I, Chandhok N, Boddu P, Pucar D, Seropian S, Gowda L, Perreault S, Wilson L, Roberts K, Foss F. Predictive Value of PET-CT in Patients with T-Cell Lymphoma Undergoing Autologous and Allogeneic Stem Cell Transplant Transplantation And Cellular Therapy 2020, 26: s244. DOI: 10.1016/j.bbmt.2019.12.492.
  • A Blinded, Prospective Study of Problematic Plan Detection During Physician Chart RoundsTalcott W, Lincoln H, Kelly J, Tressel L, Wilson L, Decker R, Evans S. A Blinded, Prospective Study of Problematic Plan Detection During Physician Chart Rounds International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s23-s24. DOI: 10.1016/j.ijrobp.2019.06.425.
  • PV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDBChowdhary M, Lee A, Gao S, Barry P, Diaz R, Bagadiya N, Park H, Yu J, Wilson L, Moran M, Higgins S, Knowlton C, Patel K. PV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDB Radiotherapy And Oncology 2019, 133: s15. DOI: 10.1016/s0167-8140(19)30465-7.
  • Higher Volume Facilities are Associated with the Delivery of Lower Dose Radiation Therapy in the Treatment of Cutaneous T-Cell LymphomaMiccio J, Wilson L, Kann B, Jairam V, Beckta J, Yeboa D. Higher Volume Facilities are Associated with the Delivery of Lower Dose Radiation Therapy in the Treatment of Cutaneous T-Cell Lymphoma International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e334-e335. DOI: 10.1016/j.ijrobp.2018.07.1027.
  • Disparities among Domestic Radiation Oncology (RO) Graduates’ Job Application Patterns and Top Choice PreferencesChowdhary M, Switchenko J, Sen N, Chhabra A, Katz L, Barry P, Wang D, Curran W, Wilson L, Abrams R, Marwaha G, Patel K. Disparities among Domestic Radiation Oncology (RO) Graduates’ Job Application Patterns and Top Choice Preferences International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e414. DOI: 10.1016/j.ijrobp.2018.07.1215.
  • Relationship between Citation-Based Scholarly Activity of United States Radiation Oncology Residents and Subsequent Choice of Academic versus Private Practice CareerMcClelland S, Mitin T, Wilson L, Thomas C, Jaboin J. Relationship between Citation-Based Scholarly Activity of United States Radiation Oncology Residents and Subsequent Choice of Academic versus Private Practice Career International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e393. DOI: 10.1016/j.ijrobp.2018.07.1165.
  • (P59) Cutaneous T-Cell Lymphoma: Trends in Radiation Dose and Patterns of CareMiccio J, Wilson L, Kann B, Yeboa D. (P59) Cutaneous T-Cell Lymphoma: Trends in Radiation Dose and Patterns of Care International Journal Of Radiation Oncology • Biology • Physics 2018, 101: e43. DOI: 10.1016/j.ijrobp.2018.02.147.
  • EP-1328: Impact of deep inspiration breath hold on heart and lung dose constraints in a large breast seriesLoganadane G, Kann B, Young M, Knowlton C, Higgins S, Belkacemi Y, Wilson L, Moran M. EP-1328: Impact of deep inspiration breath hold on heart and lung dose constraints in a large breast series Radiotherapy And Oncology 2018, 127: s727-s728. DOI: 10.1016/s0167-8140(18)31638-4.
  • EP-1321: Incidental radiation dose to the internal mammary chain in a large clinical breast seriesLoganadane G, Kann B, Young M, Knowlton C, Evans S, Higgins S, Belkacemi Y, Wilson L, Moran M. EP-1321: Incidental radiation dose to the internal mammary chain in a large clinical breast series Radiotherapy And Oncology 2018, 127: s724. DOI: 10.1016/s0167-8140(18)31631-1.
  • 441 Reduced Intensity Conditioning with Pentostatin and Low-Dose TBI in Patients with Relapsed Hematologic MalignanciesIsufi I, Seropian S, Cooper D, Roberts K, Wilson L, Girardi M, Perreault S, Foss F. 441 Reduced Intensity Conditioning with Pentostatin and Low-Dose TBI in Patients with Relapsed Hematologic Malignancies Transplantation And Cellular Therapy 2018, 24: s307. DOI: 10.1016/j.bbmt.2017.12.353.
  • Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary SyndromeKann B, Park H, Yeboa D, Aneja S, Girardi M, Foss F, Roberts K, Wilson L. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e430. DOI: 10.1016/j.ijrobp.2017.06.1632.
  • The Impact of Standardized Treatment Planning Guidelines on Treatment Plan QualityKelly J, Park H, Carlson D, Moran M, Wilson L, Young M, Higgins S, Guay D, Arthur G, Simmons W, Winter S, Evans S. The Impact of Standardized Treatment Planning Guidelines on Treatment Plan Quality International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e556. DOI: 10.1016/j.ijrobp.2017.06.1936.
  • Circulating CD4:CD8 Ratio is Prognosticator of Response to Total Skin Electron Beam Radiation in Mycoses FungoidesAn Y, Jiang W, Andraos T, Pinnix C, Milgrom S, Lloyd S, Wilson L, Dabaja B. Circulating CD4:CD8 Ratio is Prognosticator of Response to Total Skin Electron Beam Radiation in Mycoses Fungoides International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e424. DOI: 10.1016/j.ijrobp.2017.06.1618.
  • Comparison of Self-Reported Data on Student Doctor Network to Objective Data of the National Resident Matching Program for Individuals Applying to Radiation OncologySura K, Wilson L, Grills I. Comparison of Self-Reported Data on Student Doctor Network to Objective Data of the National Resident Matching Program for Individuals Applying to Radiation Oncology International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e129. DOI: 10.1016/j.ijrobp.2017.06.907.
  • Association of Preresidency Peer Reviewed Publications With Radiation Oncology Resident Choice of Academic Versus Private Practice CareerMcClelland S, Thomas C, Wilson L, Holliday E, Jaboin J. Association of Preresidency Peer Reviewed Publications With Radiation Oncology Resident Choice of Academic Versus Private Practice Career International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e127. DOI: 10.1016/j.ijrobp.2017.06.902.
  • 1341P Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNAGoldberg S, Narayan A, Narayan A, Kole A, Kole A, Decker R, Teysir J, Teysir J, Carriero N, Lee A, Nemati R, Nemati R, Nath S, Nath S, Mane S, Deng Y, Sukumar N, Sukumar N, Zelterman D, Boffa D, Politi K, Gettinger S, Wilson L, Herbst R, Patel A. 1341P Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNA Annals Of Oncology 2017, 28: v478. DOI: 10.1093/annonc/mdx380.043.
  • A Novel Prognostic Index for Ocular Adnexal LymphomaMeeks M, Park H, Yu J, Roberts K, Foss F, Wilson L. A Novel Prognostic Index for Ocular Adnexal Lymphoma Blood 2016, 128: 3597-3597. DOI: 10.1182/blood.v128.22.3597.3597.
  • Facility Case Volume and Outcomes for Intensity Modulated Radiation Therapy in Head and Neck CancerPark H, Rutter C, Lester-Coll N, Corso C, Wang E, Wilson L, Yu J, Decker R, Husain Z. Facility Case Volume and Outcomes for Intensity Modulated Radiation Therapy in Head and Neck Cancer International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e325. DOI: 10.1016/j.ijrobp.2016.06.1444.
  • Impact of Radiation Therapy Facility Case Volume on Survival in Anal CancerPark H, Stahl J, Lester-Coll N, Rutter C, Corso C, Wang E, Husain Z, Decker R, Yu J, Wilson L, Johung K. Impact of Radiation Therapy Facility Case Volume on Survival in Anal Cancer International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s188. DOI: 10.1016/j.ijrobp.2016.06.469.
  • Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025Pan H, Haffty B, Falit B, Buchholz T, Wilson L, Hahn S, Smith B. Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025 International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e394-e395. DOI: 10.1016/j.ijrobp.2016.06.1623.
  • Practice Selection of Graduating Radiation Oncology ResidentsGreen M, Ahmed A, Holliday E, Yoo S, Orman A, Deville C, Jagsi R, Wilson L. Practice Selection of Graduating Radiation Oncology Residents International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e412-e413. DOI: 10.1016/j.ijrobp.2016.06.1667.
  • Chapter 79 Mycosis FungoidesSmith G, Wilson L, Dabaja B. Chapter 79 Mycosis Fungoides 2016, 1556-1576.e4. DOI: 10.1016/b978-0-323-24098-7.00079-4.
  • Association Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung CancerWang E, Corso C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Association Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e387-e388. DOI: 10.1016/j.ijrobp.2015.07.1536.
  • Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung CancerPark H, Wang E, Corso C, Rutter C, Wilson L, Kim A, Gross C, Yu J, Decker R. Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s186-s187. DOI: 10.1016/j.ijrobp.2015.07.447.
  • Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small Cell Lung CancerWang E, Corso C, Rutter C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e388-e389. DOI: 10.1016/j.ijrobp.2015.07.1538.
  • Trends in Hospital Owned Practices Within Radiation OncologyAneja S, Smith B, Gross C, Haffty B, Wilson L, Yu J. Trends in Hospital Owned Practices Within Radiation Oncology International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e371-e372. DOI: 10.1016/j.ijrobp.2015.07.1495.
  • Trends In The Utilization Of Radiation Therapy For Early-Stage Low Grade Follicular Lymphoma: The Impact Of “Watchful Waiting” Evidence On Clinical PracticeAneja S, Wilson L, Yu J. Trends In The Utilization Of Radiation Therapy For Early-Stage Low Grade Follicular Lymphoma: The Impact Of “Watchful Waiting” Evidence On Clinical Practice International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e461-e462. DOI: 10.1016/j.ijrobp.2015.07.1726.
  • Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non–Small-Cell Lung CancerWang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non–Small-Cell Lung Cancer Journal Of Clinical Oncology 2015, 33: 2727-2734. PMID: 26101240, DOI: 10.1200/jco.2015.61.1517.
  • Association between radiation dose and outcomes with postoperative radiotherapy for N0-N1 non-small-cell-lung cancer.Wang E, Corso C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Association between radiation dose and outcomes with postoperative radiotherapy for N0-N1 non-small-cell-lung cancer. Journal Of Clinical Oncology 2015, 33: 7538-7538. DOI: 10.1200/jco.2015.33.15_suppl.7538.
  • Poorer Prognosis of African-American Patients With Mycosis Fungoides: An Analysis of the SEER Dataset, 1988 to 2008Nath SK, Yu JB, Wilson LD. Poorer Prognosis of African-American Patients With Mycosis Fungoides: An Analysis of the SEER Dataset, 1988 to 2008 Clinical Lymphoma Myeloma & Leukemia 2014, 14: 419-423. PMID: 24508350, PMCID: PMC4081527, DOI: 10.1016/j.clml.2013.12.018.
  • Skin Surface, Dermis, and Wound HealingDecker R, Strom E, Wilson L. Skin Surface, Dermis, and Wound Healing 2013, 205-226. DOI: 10.1007/978-3-540-75863-1_9.
  • Radiation Therapy In Peripheral T-Cell Lymphoma Of The Head and NeckFernandes A, Svoboda J, Nasta S, Wilson L, Plastaras J. Radiation Therapy In Peripheral T-Cell Lymphoma Of The Head and Neck Blood 2013, 122: 1795-1795. DOI: 10.1182/blood.v122.21.1795.1795.
  • Factors that Determine Academic Versus Private Practice Career Interest in Radiation Oncology Residents in the United States: Results of a Nationwide SurveyChang D, Shaffer J, Haffty B, Wilson L. Factors that Determine Academic Versus Private Practice Career Interest in Radiation Oncology Residents in the United States: Results of a Nationwide Survey International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s486. DOI: 10.1016/j.ijrobp.2013.06.1284.
  • Acute Treatment Toxicity and the Risk of Infection During Total Skin Electron Beam Therapy for Mycosis FungoidesLloyd S, Chen Z, Foss F, Girardi M, Wilson L. Acute Treatment Toxicity and the Risk of Infection During Total Skin Electron Beam Therapy for Mycosis Fungoides International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s557. DOI: 10.1016/j.ijrobp.2013.06.1475.
  • Standing on the Shoulders of Giants: Initial Results From the Radiation Oncology Academic Development and Mentorship Assessment Project (ROADMAP)Holliday E, Jagsi R, Thomas C, Wilson L, Fuller C. Standing on the Shoulders of Giants: Initial Results From the Radiation Oncology Academic Development and Mentorship Assessment Project (ROADMAP) International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s502-s503. DOI: 10.1016/j.ijrobp.2013.06.1327.
  • LymphomaKelsey C, Wilson L. Lymphoma 2013, 257-278. DOI: 10.1007/174_2013_830.
  • Resident-Reported Brachytherapy Experience in ACGME-Accredited Radiation Oncology Training ProgramsLee W, Gaspar L, Shrieve D, Wilson L, Griem K, Compton J, Amdur R. Resident-Reported Brachytherapy Experience in ACGME-Accredited Radiation Oncology Training Programs Brachytherapy 2013, 12: s38-s39. DOI: 10.1016/j.brachy.2013.01.069.
  • A 35-year History of Radiation Therapy Utilization Across the United StatesAneja S, Roberts K, Wilson L, Haffty B, Montana G, Yu J. A 35-year History of Radiation Therapy Utilization Across the United States International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s546-s547. DOI: 10.1016/j.ijrobp.2012.07.1457.
  • Scholastic Activity Among Radiation Oncology Residents at US Academic Institutions: A Benchmark Analysis of H-IndexRana S, Holliday E, Fuller C, Jagsi R, Wilson L, Choi M, Thomas C. Scholastic Activity Among Radiation Oncology Residents at US Academic Institutions: A Benchmark Analysis of H-Index International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s547. DOI: 10.1016/j.ijrobp.2012.07.1458.
  • Gender Differences in Publication Productivity, Academic Position, and Career Duration Among Current Academic Radiation Oncology FacultyHolliday E, Choi M, Jagsi R, Wilson L, Thomas C, Fuller C. Gender Differences in Publication Productivity, Academic Position, and Career Duration Among Current Academic Radiation Oncology Faculty International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s547-s548. DOI: 10.1016/j.ijrobp.2012.07.1460.
  • Chapter 77 Mycosis FungoidesSmith B, Jones G, Wilson L. Chapter 77 Mycosis Fungoides 2012, 1583-1603. DOI: 10.1016/b978-1-4377-1637-5.00087-0.
  • Prophylactic Cranial Irradiation for High-Risk Patients with Locally Advanced Non-small Cell Lung CancerPark H, Decker R, Wilson L, Yu J. Prophylactic Cranial Irradiation for High-Risk Patients with Locally Advanced Non-small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s627. DOI: 10.1016/j.ijrobp.2011.06.1866.
  • Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation StudyDecker R, Gettinger S, Glazer P, Wilson L. Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s574-s575. DOI: 10.1016/j.ijrobp.2011.06.1074.
  • MicroRNA Profiling of Cutaneous T-cell Lymphoma Cell Lines: Implications for Pathophysiology and TherapyHansen J, Reza F, Nallur S, Lewis J, Carlson K, Lin W, Weidhaas J, Wilson L, Girardi M. MicroRNA Profiling of Cutaneous T-cell Lymphoma Cell Lines: Implications for Pathophysiology and Therapy International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s22. DOI: 10.1016/j.ijrobp.2011.06.045.
  • Breast Conservation Therapy for Ductal Carcinoma In Situ (DCIS): Is there a difference in Clinical-Pathologic Features and Long Term Outcomes in Occult, Mammographically-Detected Disease Compared with DCIS Presenting with Physical Findings?Bai H, Lannin D, Higgins S, Motwani S, Hafty B, Goyal S, Wilson L, Evans S, Moran M. Breast Conservation Therapy for Ductal Carcinoma In Situ (DCIS): Is there a difference in Clinical-Pathologic Features and Long Term Outcomes in Occult, Mammographically-Detected Disease Compared with DCIS Presenting with Physical Findings? International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s245. DOI: 10.1016/j.ijrobp.2011.06.1716.
  • Stage Presentation and Clinical Outcome by Race for Patients with Mycosis Fungoides: A National Population Based Registry StudyWilson L, Hinds G, Yu J. Stage Presentation and Clinical Outcome by Race for Patients with Mycosis Fungoides: A National Population Based Registry Study International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s634. DOI: 10.1016/j.ijrobp.2011.06.1882.
  • A prospective, multicenter trial of complementary and alternative medicine (CAM) utilization by patients undergoing definitive breast radiotherapy.Moran M, Yang J, Ma S, Gaudreau B, Higgins S, Weidhaas J, Wilson L, Peschel R, Fass D, Rockwell S. A prospective, multicenter trial of complementary and alternative medicine (CAM) utilization by patients undergoing definitive breast radiotherapy. Journal Of Clinical Oncology 2011, 29: 241-241. DOI: 10.1200/jco.2011.29.27_suppl.241.
  • Impact of using Different Tissue Heterogeneity Correction Algorithms on the Successful Implementation of Stereotactic Body Radiotherapy Programs for Lung TumorsChen Z, Deng J, Decker R, Roberts K, Wilson L, Nath R. Impact of using Different Tissue Heterogeneity Correction Algorithms on the Successful Implementation of Stereotactic Body Radiotherapy Programs for Lung Tumors International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s456-s457. DOI: 10.1016/j.ijrobp.2008.06.1849.
  • Evaluation of the Role of Surgery in the Management of Limited/Early Stage (I-II) Small Cell Lung Cancer from the SEER database (1988-2004)Wilson L, Decker R, Yu J. Evaluation of the Role of Surgery in the Management of Limited/Early Stage (I-II) Small Cell Lung Cancer from the SEER database (1988-2004) International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s448. DOI: 10.1016/j.ijrobp.2008.06.1830.
  • Skip Metastasis and Bilateral Lymphatic Involvement in Oral Cavity Squamous Cell CarcinomaDecker R, Yu J, Wilson L, Lloyd S. Skip Metastasis and Bilateral Lymphatic Involvement in Oral Cavity Squamous Cell Carcinoma International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s160-s161. DOI: 10.1016/j.ijrobp.2008.06.505.
  • Impact of Respiratory Motion on the Calculation of Lung Dose in Stereotactic Body RadiotherapyLawrence K, Picone J, Yang T, Trumpore S, Nath R, Decker R, Wilson L, Chen Z. Impact of Respiratory Motion on the Calculation of Lung Dose in Stereotactic Body Radiotherapy International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s675-s676. DOI: 10.1016/j.ijrobp.2008.06.385.
  • Adjuvant Radiation Therapy for Adenoid Cystic Carcinoma of the Head and NeckLloyd S, Wilson L, Decker R. Adjuvant Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s384-s385. DOI: 10.1016/j.ijrobp.2008.06.1247.
  • ReplyHeald P, Subtil A, Breneman D, Wilson L. Reply Journal Of The American Academy Of Dermatology 2008, 59: 165. DOI: 10.1016/j.jaad.2008.01.022.
  • Advances in Radiotherapy for Lung CancerDecker1 R, Wilson1 L. Advances in Radiotherapy for Lung Cancer Seminars In Respiratory And Critical Care Medicine 2008, 29: 285-290. PMID: 18506666, DOI: 10.1055/s-2008-1076748.
  • Successful therapy of cutaneous Tcell lymphomaHeald P, Latkowski J, Wilson L, Mark L. Successful therapy of cutaneous Tcell lymphoma Expert Review Of Dermatology 2008, 3: 99-110. DOI: 10.1586/17469872.3.1.99.
  • IMRT Allows Further Dose Escalation in Selected Patients With Stage III Non-Small Cell Lung CancerYang T, Lawrence K, Chen Z, Padmanabha S, Wilson L, Decker R. IMRT Allows Further Dose Escalation in Selected Patients With Stage III Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s531. DOI: 10.1016/j.ijrobp.2007.07.1768.
  • Surveillance, Epidemiology, and End Results (SEER) Database Analysis of Stage IE Primary CD30+ Cutaneous T-Cell Lymphoma (PCCTCL)Yu J, Blitzblau R, Decker R, Housman D, Wilson L. Surveillance, Epidemiology, and End Results (SEER) Database Analysis of Stage IE Primary CD30+ Cutaneous T-Cell Lymphoma (PCCTCL) International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s536-s537. DOI: 10.1016/j.ijrobp.2007.07.1777.
  • Surveillance, Epidemiology, and End Results (SEER) Database Analysis of Microcystic Adnexal Carcinoma (Sclerosing Sweat Duct Carcinoma) of the SkinPatel S, Yu J, Decker R, Blitzblau R, Housman D, Wilson L. Surveillance, Epidemiology, and End Results (SEER) Database Analysis of Microcystic Adnexal Carcinoma (Sclerosing Sweat Duct Carcinoma) of the Skin International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s755-s756. DOI: 10.1016/j.ijrobp.2007.07.2319.
  • National Residency Matching Program (NRMP) Results for Radiation Oncology, 2007 UpdateWilson L, Yu J, Haffty B. National Residency Matching Program (NRMP) Results for Radiation Oncology, 2007 Update International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s473-s474. DOI: 10.1016/j.ijrobp.2007.07.1668.
  • Analysis of Gastric MALT Lymphomas Identified in the SEER DatabaseBlitzblau R, Yu J, Wilson L, Roberts K. Analysis of Gastric MALT Lymphomas Identified in the SEER Database International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s537-s538. DOI: 10.1016/j.ijrobp.2007.07.1779.
  • Characterization of Non-Gastric MALT Lymphomas Identified in the SEER DatabaseRoberts K, Blitzblau R, Wilson L. Characterization of Non-Gastric MALT Lymphomas Identified in the SEER Database International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s532-s533. DOI: 10.1016/j.ijrobp.2007.07.1771.
  • In ReplyLally B, Zelterman D, Colasanto J, Haffty B, Detterbeck F, Wilson L. In Reply Journal Of Clinical Oncology 2007, 25: 460-461. DOI: 10.1200/jco.2006.09.4771.
  • In ReplyLally B, Zelterman D, Colasanto J, Haffty B, Detterbeck F, Wilson L. In Reply Journal Of Clinical Oncology 2006, 24: 5612-5613. DOI: 10.1200/jco.2006.09.1819.
  • 1036 The Role of Radiation Therapy in Malignant Thymomas: A Population-Based StudyHousman D, Smith B, Detterbeck F, Wilson L. 1036 The Role of Radiation Therapy in Malignant Thymomas: A Population-Based Study International Journal Of Radiation Oncology • Biology • Physics 2006, 66: s150. DOI: 10.1016/j.ijrobp.2006.07.301.
  • 2450 Radiation Oncology National Resident Matching Program Results, 2006Wilson L. 2450 Radiation Oncology National Resident Matching Program Results, 2006 International Journal Of Radiation Oncology • Biology • Physics 2006, 66: s459-s460. DOI: 10.1016/j.ijrobp.2006.07.861.
  • The Impact of Radiotherapy for Post-operative Patients with Stage II or Stage III Non-Small Cell Lung Cancer Utilizing the Surveillance, Epidemiology, and End Results DatabaseLally B, Wilson L. The Impact of Radiotherapy for Post-operative Patients with Stage II or Stage III Non-Small Cell Lung Cancer Utilizing the Surveillance, Epidemiology, and End Results Database International Journal Of Radiation Oncology • Biology • Physics 2005, 63: s102-s103. DOI: 10.1016/j.ijrobp.2005.07.176.
  • Capecitabine (XEL) and Mitomycin-C (MMC) used concurrently with accelerated concomitant boost radiation therapy (CB-RT) in head and neck cancer (SCCHN): Preliminary results of a phase I clinical trialHaffty B, Psyrri A, Joe J, Slater D, Zaheer W, Wilson L, Son Y, Sasaki C, Chu E. Capecitabine (XEL) and Mitomycin-C (MMC) used concurrently with accelerated concomitant boost radiation therapy (CB-RT) in head and neck cancer (SCCHN): Preliminary results of a phase I clinical trial Journal Of Clinical Oncology 2005, 23: 5595-5595. DOI: 10.1200/jco.2005.23.16_suppl.5595.
  • Evaluation of second malignancy in patients with T1-T4 squamous cell carcinoma (SCC) of the larynxColasanto J, Haffty B, Lally B, Wilson L. Evaluation of second malignancy in patients with T1-T4 squamous cell carcinoma (SCC) of the larynx International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s505. DOI: 10.1016/j.ijrobp.2004.07.445.
  • Cutaneous B-cell lymphoma: An emerging clinical entitySmith B, Smith G, Cooper D, Wilson L. Cutaneous B-cell lymphoma: An emerging clinical entity International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s220. DOI: 10.1016/j.ijrobp.2004.06.175.
  • Concurrent chemo-radiotherapy with mitomycinc (MC) compared to porfiromycin (PO) in squamous cell carcinoma of the head and neck (SCCHN): final results of a randomized clinical trialHaffty B, Son Y, Wilson L, Cho E, Papac R, Fischer D, Rockwell S, Sartorelli A, Sasaki C, Fischer J. Concurrent chemo-radiotherapy with mitomycinc (MC) compared to porfiromycin (PO) in squamous cell carcinoma of the head and neck (SCCHN): final results of a randomized clinical trial International Journal Of Radiation Oncology • Biology • Physics 2003, 57: s246. DOI: 10.1016/s0360-3016(03)01076-9.
  • Local superficial radiotherapy (LSRT) for newly diagnosed stage IA patch-plaque mycosis fungoides (MF) with only one, two or three presenting lesionsWong R, Jones G, Farrar N, Sur R, Wilson L. Local superficial radiotherapy (LSRT) for newly diagnosed stage IA patch-plaque mycosis fungoides (MF) with only one, two or three presenting lesions International Journal Of Radiation Oncology • Biology • Physics 2003, 57: s289-s290. DOI: 10.1016/s0360-3016(03)01145-3.
  • Disseminated Herpes Simplex after Total Skin Electron Beam Radiotherapy for Mycosis FungoidesSmith B, Son C, Wilson L. Disseminated Herpes Simplex after Total Skin Electron Beam Radiotherapy for Mycosis Fungoides Journal Of The Royal Society Of Medicine 2003, 96: 500-501. DOI: 10.1177/014107680309601009.
  • Evaluation of Second Malignancy and Local Recurrence in Patients with T1 and T2 Squamo Cell Carcinoma (SCC) of the LarynxColasanto J, Wilson L, Haffty B. Evaluation of Second Malignancy and Local Recurrence in Patients with T1 and T2 Squamo Cell Carcinoma (SCC) of the Larynx The Cancer Journal 2002, 8: 491. DOI: 10.1097/00130404-200211000-00035.
  • Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoidesWilson L, Jones G, Kim D, Rosenthal D, Christensen I, Edelson R, Heald P, Kacinski B. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides Journal Of The American Academy Of Dermatology 2000, 43: 54-60. PMID: 10863224, DOI: 10.1067/mjd.2000.105510.
  • PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patientsPeschel R, Robnett T, Hesse D, King C, Ennis R, Schiff P, Wilson L. PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients International Journal Of Cancer 2000, 90: 29-36. PMID: 10725855, DOI: 10.1002/(sici)1097-0215(20000220)90:1<29::aid-ijc4>3.0.co;2-5.
  • Prognostic significance of cyclin D1 protein levels in early‐stage larynx cancer treated with primary radiationYoo S, Carter D, Turner B, Sasaki C, Son Y, Wilson L, Glazer P, Haffty B. Prognostic significance of cyclin D1 protein levels in early‐stage larynx cancer treated with primary radiation International Journal Of Cancer 2000, 90: 22-28. PMID: 10725854, DOI: 10.1002/(sici)1097-0215(20000220)90:1<22::aid-ijc3>3.0.co;2-t.
  • The changing survival of patients with mycosis fungoidesJones G, Wilson L. The changing survival of patients with mycosis fungoides Cancer 1999, 86: 191-193. PMID: 10391580, DOI: 10.1002/(sici)1097-0142(19990701)86:1<191::aid-cncr26>3.0.co;2-e.
  • Total skin electron radiation for patients with erythrodermic cutaneous T‐cell lymphoma (mycosis fungoides and the Sézary syndrome)Jones G, Rosenthal D, Wilson L. Total skin electron radiation for patients with erythrodermic cutaneous T‐cell lymphoma (mycosis fungoides and the Sézary syndrome) Cancer 1999, 85: 1985-1995. PMID: 10223240, DOI: 10.1002/(sici)1097-0142(19990501)85:9<1985::aid-cncr16>3.0.co;2-o.
  • Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides).Thayu M, Tallini G, Glusac E, Kacinski B, Wilson L. Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides). The Yale Journal Of Biology And Medicine 1999, 72: 365-75. PMID: 11138932, PMCID: PMC2579043.
  • Intraoperative brachytherapy, laryngopharyngoesophagectomy, and gastric transposition for patients with recurrent hypopharyngeal and cervical esophageal carcinomaWilson L, Chung J, Haffty B, Cahow E, Sasaki C, Son Y. Intraoperative brachytherapy, laryngopharyngoesophagectomy, and gastric transposition for patients with recurrent hypopharyngeal and cervical esophageal carcinoma The Laryngoscope 1998, 108: 1504-1508. PMID: 9778290, DOI: 10.1097/00005537-199810000-00014.
  • Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and ChemotherapyTurner B, Knisely J, Kacinski B, Haffty B, Gumbs A, Roberts K, Frank A, Peschel R, Rutherford T, Edraki B, Kohorn E, Chambers S, Schwartz P, Wilson L. Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and Chemotherapy International Journal Of Radiation Oncology • Biology • Physics 1998, 40: 77-84. PMID: 9422561, DOI: 10.1016/s0360-3016(97)00581-6.
  • Local Superficial Radiotherapy in the Management of Minimal Stage IA Cutaneous T-Cell Lymphoma (Mycosis Fungoides)Wilson L, Kacinski B, Jones G. Local Superficial Radiotherapy in the Management of Minimal Stage IA Cutaneous T-Cell Lymphoma (Mycosis Fungoides) International Journal Of Radiation Oncology • Biology • Physics 1998, 40: 109-115. PMID: 9422565, DOI: 10.1016/s0360-3016(97)00553-1.
  • Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)Quirós P, Jones G, Kacinski B, Braverman I, Heald P, Edelson R, Wilson L. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides) International Journal Of Radiation Oncology • Biology • Physics 1997, 38: 1027-1035. PMID: 9276369, DOI: 10.1016/s0360-3016(97)00127-2.
  • Mycosis fungoides and total skin electron beam radiation.Jones G, Wilson L. Mycosis fungoides and total skin electron beam radiation. Blood 1997, 89: 3062-4. PMID: 9108429, DOI: 10.1182/blood.v89.8.3062.
  • Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neckHaffty B, Son Y, Wilson L, Papac R, Fischer D, Rockwell S, Sartorelli A, Ross D, Sasaki C, Fischer J. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck International Journal Of Cancer 1997, 5: 235-245. PMID: 9372546, DOI: 10.1002/(sici)1520-6823(1997)5:5<235::aid-roi4>3.0.co;2-z.
  • Treatment of recurrent pelvic and selected primary gynecologic malignancies with 241AmChung J, Roberts K, Peschel R, Nath R, Pourang R, Kacinski B, Wilson L. Treatment of recurrent pelvic and selected primary gynecologic malignancies with 241Am International Journal Of Cancer 1997, 5: 227-234. PMID: 9372545, DOI: 10.1002/(sici)1520-6823(1997)5:5<227::aid-roi3>3.0.co;2-#.
  • 2174 Local superficial radiotherapy in the management of minimal stage IA Mycosis FungoidesWilson L, Kacinski B, Jones G. 2174 Local superficial radiotherapy in the management of minimal stage IA Mycosis Fungoides International Journal Of Radiation Oncology • Biology • Physics 1997, 39: 327. DOI: 10.1016/s0360-3016(97)80941-8.
  • Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphomaWilson L, Quiros P, Kolenik S, Heald P, Braverman I, Edelson R, Kacinski B. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma Journal Of The American Academy Of Dermatology 1996, 35: 69-73. PMID: 8682967, DOI: 10.1016/s0190-9622(96)90499-5.
  • Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T‐cell lymphoma treated with total skin electron beam radiation therapyQuiros P, Kacinski B, Wilson L. Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T‐cell lymphoma treated with total skin electron beam radiation therapy Cancer 1996, 77: 1912-1917. PMID: 8646693, DOI: 10.1002/(sici)1097-0142(19960501)77:9<1912::aid-cncr23>3.0.co;2-1.
  • 2159 Total skin electron beam therapy(TSEBT) followed by adjuvant psoralen/ultraviolet A light (PUVA) in the management of patients with T1 and T2 cutaneous T-cell lymphoma (CTCL)Quiros P, Kacinski B, Heald P, Edelson R, Braverman I, Wilson L. 2159 Total skin electron beam therapy(TSEBT) followed by adjuvant psoralen/ultraviolet A light (PUVA) in the management of patients with T1 and T2 cutaneous T-cell lymphoma (CTCL) International Journal Of Radiation Oncology • Biology • Physics 1996, 36: 355. DOI: 10.1016/s0360-3016(97)85733-1.
  • 2110 Porfiromycin as an adjunct to radiation therapy in squamous cell carcinoma of the head and neckHaffty B, Son Y, Papac R, Fischer D, Wilson L, Rockwell S, Sartorelli A, Sasaki C, Fischer J. 2110 Porfiromycin as an adjunct to radiation therapy in squamous cell carcinoma of the head and neck International Journal Of Radiation Oncology • Biology • Physics 1996, 36: 331. DOI: 10.1016/s0360-3016(97)85686-6.
  • Cutaneous metastases in head and neck cancerHerrick B, Wilson L, Ross D, Sasaki C, Son Y. Cutaneous metastases in head and neck cancer International Journal Of Cancer 1996, 4: 176-184. DOI: 10.1002/(sici)1520-6823(1996)4:4<176::aid-roi5>3.0.co;2-v.
  • 2158 Management of patients with T4 cutaneous T-cell lymphoma(CTCL) with total skin electron beam therapy(TSEBT) and adjuvant extracorporeal photochemotherapy(ECP)Wilson L, Quiros P, Edelson R, Heald P, Kacinski B. 2158 Management of patients with T4 cutaneous T-cell lymphoma(CTCL) with total skin electron beam therapy(TSEBT) and adjuvant extracorporeal photochemotherapy(ECP) International Journal Of Radiation Oncology • Biology • Physics 1996, 36: 355. DOI: 10.1016/s0360-3016(97)85734-3.
  • Subareolar breast cancer: Long-term results with conservative surgery and radiation therapyHaffty B, Wilson L, Smith R, Fischer D, Beinfield M, Ward B, McKhann C. Subareolar breast cancer: Long-term results with conservative surgery and radiation therapy International Journal Of Radiation Oncology • Biology • Physics 1995, 33: 53-57. PMID: 7642431, DOI: 10.1016/0360-3016(95)00165-u.
  • Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapyWilson L, Licata A, Braverman I, Edelson R, Heald P, Feldman A, Kacinski B. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy International Journal Of Radiation Oncology • Biology • Physics 1995, 32: 987-995. PMID: 7607973, DOI: 10.1016/0360-3016(95)00073-8.
  • Malignant Melanoma and Other Second Cutaneous Malignancies in Cutaneous T-Cell Lymphoma: The Influence of Additional Therapy After Total Skin Electron Beam RadiationLicata A, Wilson L, Braverman I, Feldman A, Kacinski B. Malignant Melanoma and Other Second Cutaneous Malignancies in Cutaneous T-Cell Lymphoma: The Influence of Additional Therapy After Total Skin Electron Beam Radiation JAMA Dermatology 1995, 131: 432-435. DOI: 10.1001/archderm.1995.01690160060009.
  • In response to Drs. Breneman and BrenemanWilson L, Kacinski B. In response to Drs. Breneman and Breneman International Journal Of Radiation Oncology • Biology • Physics 1995, 32: 274. DOI: 10.1016/0360-3016(95)90311-9.
  • 1007 Treatment of selected primary gynecologic and pelvic malignancies with 241AmericiumChung J, Peschel R, Kacinski B, Nath R, Pourang R, Roberts K, Fischer D, Chambers J, Schwartz P, Wilson L. 1007 Treatment of selected primary gynecologic and pelvic malignancies with 241Americium International Journal Of Radiation Oncology • Biology • Physics 1995, 32: 226. DOI: 10.1016/0360-3016(95)97833-m.
  • Location of the prostatic apex and its relationship to the ischial tuberositiesWilson L, Ennis R, Percarpio B, Peschel R. Location of the prostatic apex and its relationship to the ischial tuberosities International Journal Of Radiation Oncology • Biology • Physics 1994, 29: 1133-1138. PMID: 8083083, DOI: 10.1016/0360-3016(94)90410-3.
  • Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patientHaffty B, Wilmarth L, Wilson L, Fischer D, Beinfield M, McKhann C. Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient Cancer 1994, 73: 2543-2548. PMID: 8174051, DOI: 10.1002/1097-0142(19940515)73:10<2543::aid-cncr2820731015>3.0.co;2-7.
  • Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapyWilson L, Cooper D, Goodrich A, Friedman N, Feldman A, Braverman I, Kacinski B. Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy International Journal Of Radiation Oncology • Biology • Physics 1994, 28: 829-837. PMID: 8138435, DOI: 10.1016/0360-3016(94)90102-3.
  • The utility of adjuvant psoralen + ultraviolet-a light [PUVA] therapy in maintaining cutaneous remission in T1 and T2 CTCL (mycosis fungoides) treated with total skin electron beam radiation therapy [TSEBT]Kolenli S, Kacinski B, Quiros P, Wilson L, Heald P, Edelson R, Braverman I. The utility of adjuvant psoralen + ultraviolet-a light [PUVA] therapy in maintaining cutaneous remission in T1 and T2 CTCL (mycosis fungoides) treated with total skin electron beam radiation therapy [TSEBT] International Journal Of Radiation Oncology • Biology • Physics 1994, 30: 266. DOI: 10.1016/0360-3016(94)90820-6.
  • Novel prognostic factors predictive of prolonged relapse-free and overall survival in advanced stage CTCL (mycosis fungoides) patients treated with total skin electron beam therapyKacinski B, Wilson L, Quiros P, Kolenik S, Heald P, Edelson R, Braverman I. Novel prognostic factors predictive of prolonged relapse-free and overall survival in advanced stage CTCL (mycosis fungoides) patients treated with total skin electron beam therapy International Journal Of Radiation Oncology • Biology • Physics 1994, 30: 268. DOI: 10.1016/0360-3016(94)90823-0.
  • Additional courses of total skin electron beam therapy [TSEBT] in the retreatment of patients with cutaneous t-cell lymphoma [CTCL]Wilson L, Quiros P, Kolenik S, Heald P, Braverman I, Edelson R, Kacinski B. Additional courses of total skin electron beam therapy [TSEBT] in the retreatment of patients with cutaneous t-cell lymphoma [CTCL] International Journal Of Radiation Oncology • Biology • Physics 1994, 30: 269. DOI: 10.1016/0360-3016(94)90825-7.
  • Subareolar breast cancer: long term results with conservative surgery and radiation therapyHaffty B, Wilson L, Smith R, Beinfield M, Ward B, McKhann C. Subareolar breast cancer: long term results with conservative surgery and radiation therapy International Journal Of Radiation Oncology • Biology • Physics 1994, 30: 154. DOI: 10.1016/0360-3016(94)90628-9.
  • Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancersWilson L, Beinfield M, McKhann C, Haffty B. Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancers Cancer 1993, 72: 137-142. PMID: 8389664, DOI: 10.1002/1097-0142(19930701)72:1<137::aid-cncr2820720126>3.0.co;2-e.
  • The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III–IV gliomasPeschel R, Wilson L, Haffty B, Papadopoulos D, Rosenzweig K, Feltes M. The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III–IV gliomas International Journal Of Radiation Oncology • Biology • Physics 1993, 26: 539-544. PMID: 8514549, DOI: 10.1016/0360-3016(93)90973-y.
  • Increased incidence of malignant melanoma and other second cutaneous malignancies after total skin electron beam therapy (TSEBT) for CTCL (mycosis fungoldes)Goodrich A, Wilson L, Braverman I, Kacinski B. Increased incidence of malignant melanoma and other second cutaneous malignancies after total skin electron beam therapy (TSEBT) for CTCL (mycosis fungoldes) International Journal Of Radiation Oncology • Biology • Physics 1993, 27: 187. DOI: 10.1016/0360-3016(93)90728-e.
  • Adjuvant Extracorporeal Photoimmunotherapy or adjuvant adriamyciwcytoxan chemotherapy both prolong survival for cutaneous T-cell lymphoma (CTCL, MYCOSIS FUNGOIDES) patients treated with total skin electron beam therapy (TSEBT).Kacinaki B, Wilson L, Goodrich A, Edelson R, Heald P, Braverman I. Adjuvant Extracorporeal Photoimmunotherapy or adjuvant adriamyciwcytoxan chemotherapy both prolong survival for cutaneous T-cell lymphoma (CTCL, MYCOSIS FUNGOIDES) patients treated with total skin electron beam therapy (TSEBT). International Journal Of Radiation Oncology • Biology • Physics 1993, 27: 186-187. DOI: 10.1016/0360-3016(93)90727-d.
  • Identification of nitroxide radioprotectors.Hahn S, Wilson L, Krishna C, Liebmann J, DeGraff W, Gamson J, Samuni A, Venzon D, Mitchell J. Identification of nitroxide radioprotectors. Radiation Research 1992, 132: 87-93. PMID: 1410280, DOI: 10.2307/3578338.
  • Tempol, a stable free radical, is a novel murine radiation protector.Hahn S, Tochner Z, Krishna C, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell J. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Research 1992, 52: 1750-3. PMID: 1551104.
  • In vitro/in vivo radiation protection by nitroxide stable free radicalsHahn S, Wilson L, Tochner Z, Krishna C, Samuni A, Mitchell J, Russo A. In vitro/in vivo radiation protection by nitroxide stable free radicals Free Radical Biology And Medicine 1990, 9: 171. DOI: 10.1016/0891-5849(90)90780-m.

Clinical Trials

ConditionsStudy Title
Breast - Female; BreastTAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Edit Profile